Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025

Summary by AI BETAClose X

Vivoryon Therapeutics N.V. will report its third quarter financial results for the period ended September 30, 2025, and provide an operational update on December 4, 2025. The company, which is developing small molecule medicines for inflammatory and fibrotic disorders, particularly kidney diseases, will host a public conference call and webcast to discuss its progress.

Disclaimer*

UK 100

Latest directors dealings